Invesco
KRTX

Invesco’s Karuna Therapeutics, Inc. Common Stock KRTX Stock Holding History

Invesco’s Portfolio KRTX Stock Details KRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-319,136
Closed -$101M – 3972
2023
Q4 		$101M Sell
319,136
-45,998
-13% -$8.94M 0.02% 758
2023
Q3 		$61.7M Sell
365,134
-30,423
-8% -$5.72M 0.02% 870
2023
Q2 		$85.8M Buy
395,557
+62,602
+19% +$13.4M 0.02% 765
2023
Q1 		$60.5M Buy
332,955
+29,454
+10% +$5.63M 0.02% 869
2022
Q4 		$59.6M Sell
303,501
-3,394
-1% -$728K 0.02% 872
2022
Q3 		$69M Buy
306,895
+293,854
+2,253% +$59.5M 0.02% 788
2022
Q2 		$1.65M Buy
13,041
+878
+7% +$101K ﹤0.01% 2785
2022
Q1 		$1.54M Buy
12,163
+467
+4% +$52.6K ﹤0.01% 2888
2021
Q4 		$1.53M Sell
11,696
-889
-7% -$115K ﹤0.01% 2900
2021
Q3 		$1.54M Buy
12,585
+1,595
+15% +$184K ﹤0.01% 2928
2021
Q2 		$1.25M Buy
10,990
+4,978
+83% +$582K ﹤0.01% 3040
2021
Q1 		$723K Buy
6,012
+2,780
+86% +$315K ﹤0.01% 3190
2020
Q4 		$328K Buy
+3,232
New +$299K ﹤0.01% 3381
2020
Q3 		– Sell
-111,365
Closed -$12.4M – 3704
2020
Q2 		$12.4M Buy
+111,365
New +$9.68M ﹤0.01% 1524

Other funds holding KRTX

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
S
Sachetta Lynnfield, Massachusetts $206M AUM 26.19% 1-Year Est. Return

Invesco's KRTX Position: Q1 2024 in Review

Invesco sold out of Karuna Therapeutics, Inc. Common Stock (KRTX) in Q1 2024, closing a stake of 319,136 shares — an estimated $101M sold.

Invesco first reported a position in KRTX in Q2 2020 and held it in 14 quarters. The position peaked at $101M in Q4 2023. 2 funds tracked by Wall St. Rank hold KRTX as of Q1 2024.

  • Invesco reported no remaining Karuna Therapeutics, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
  • Invesco sold 319,136 Karuna Therapeutics, Inc. Common Stock shares in Q1 2024, an estimated $101M.
  • Invesco first reported a position in Karuna Therapeutics, Inc. Common Stock in Q2 2020 and held it in 14 quarters.
  • Invesco's Karuna Therapeutics, Inc. Common Stock position peaked at $101M in Q4 2023.
  • 2 funds tracked by Wall St. Rank held Karuna Therapeutics, Inc. Common Stock as of Q1 2024.

Based on Invesco's 13F filing for Q1 2024, filed 14 May 2024.